PDL BioPharma, Inc. (PDLI) financial statements (2021 and earlier)

Company profile

Business Address 59 DAMONTE RANCH PARKWAY
RENO, NV 89521
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

8/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 193395532242220294
Cash and cash equivalents 193395527147219291
Short-term investments   59512
Receivables 6685851515858
Inventory, net of allowances, customer advances and progress billings 401993  
Inventory 401993  
Derivative instruments and hedges, assets     33
Deferred tax assets   10
Other undisclosed current assets 151914201
Total current assets: 314517640398283356
Noncurrent Assets
Property, plant and equipment 677000
Long-term investments and receivables 1194235307306
Long-term investments   7575  
Accounts and financing receivable, after allowance for credit loss 1119160307306
Intangible assets, net (including goodwill) 2351216229  
Intangible assets, net (excluding goodwill) 2351216229  
Derivative instruments and hedges      1
Other noncurrent assets 249117128
Other undisclosed noncurrent assets 348378275347415292
Total noncurrent assets: 402447603817733606
TOTAL ASSETS: 7169641,2431,2151,016962
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 465267421220
Accounts payable 171320700
Accrued liabilities 2839463189
Employee-related liabilities      1
Taxes payable 001533
Interest and dividends payable      6
Debt   126 25175
Other undisclosed current liabilities    88 (8)
Total current liabilities: 465219313037188
Noncurrent Liabilities
Long-term debt and lease obligation 27125117232233276
Long-term debt, excluding current maturities 27125117232233276
Liabilities, other than long-term debt 505787975175
Accounts payable and accrued liabilities      11
Deferred compensation liability, classified      1
Liability for uncertainty in income taxes      26
Other liabilities 505745555138
Business combination, contingent consideration, liability   4243  
Other undisclosed noncurrent liabilities      (38)
Total noncurrent liabilities: 77181204330283314
Total liabilities: 123234397460320502
Stockholders' equity
Stockholders' equity attributable to parent 593730846751696460
Common stock 112222
Treasury stock, value  (2)    
Additional paid in capital (79)(98)(102)(108)(118)(120)
Accumulated other comprehensive income   1 23
Retained earnings 671829946857810576
Stockholders' equity attributable to noncontrolling interest(0)0  4  
Other undisclosed stockholders' equity426      
Total stockholders' equity:425593730846755696460
TOTAL LIABILITIES AND EQUITY:4257169641,2431,2151,016962

Income statement (P&L) ($ in millions)

8/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 55198320244590581
Revenue, net1043211
Cost of revenue (54)(48)(31)(4)  
Cost of goods and services sold (6)(15)(27)(12)  
Gross profit: 1150290240590581
Operating expenses (155)(249)(126)(115)(40)(35)
Other undisclosed operating income 5448314  
Operating income (loss): (100)(51)194129550546
Nonoperating income (expense) 26(5)(9)(20)(20)(45)
Investment income, nonoperating 6711100
Interest and debt expense (8)(12)(20)(2)6(45)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 812202(6)45
Income (loss) from continuing operations before income taxes: (74)(56)185109530501
Income tax expense (benefit) 3(13)(74)(46)(197)(179)
Net income (loss): (71)(69)11164333322
Other undisclosed net income (loss) attributable to parent 0 0(0)  
Net income (loss) available to common stockholders, diluted: (70)(69)11164333322

Comprehensive Income ($ in millions)

8/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss): (71)(69)11164333322
Other comprehensive income (loss)  (1)1(2)(1)8
Comprehensive income (loss): (71)(70)11261332330
Comprehensive income (loss), net of tax, attributable to noncontrolling interest 0 0(0)  
Comprehensive income (loss), net of tax, attributable to parent: (70)(70)11261332330

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: